Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Centessa Pharmaceuticals (CNTA) Other Non Operating Income: 2019-2024

Historic Other Non Operating Income for Centessa Pharmaceuticals (CNTA) over the last 6 years, with Dec 2024 value amounting to -$34.1 million.

  • Centessa Pharmaceuticals' Other Non Operating Income fell 149.40% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$33.6 million, marking a year-over-year decrease of 2492.73%. This contributed to the annual value of -$34.1 million for FY2024, which is 528.17% down from last year.
  • Latest data reveals that Centessa Pharmaceuticals reported Other Non Operating Income of -$34.1 million as of FY2024, which was down 528.17% from -$5.4 million recorded in FY2023.
  • Centessa Pharmaceuticals' Other Non Operating Income's 5-year high stood at $2.3 million during FY2022, with a 5-year trough of -$34.1 million in FY2024.
  • Moreover, its 3-year median value for Other Non Operating Income was -$5.4 million (2023), whereas its average is -$12.4 million.
  • As far as peak fluctuations go, Centessa Pharmaceuticals' Other Non Operating Income plummeted by 2,919.35% in 2021, and later surged by 153.59% in 2022.
  • Centessa Pharmaceuticals' Other Non Operating Income (Yearly) stood at $155,000 in 2020, then crashed by 2,919.35% to -$4.4 million in 2021, then soared by 153.59% to $2.3 million in 2022, then tumbled by 331.77% to -$5.4 million in 2023, then slumped by 528.17% to -$34.1 million in 2024.